Previous 10 | Next 10 |
Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products in...
Talking CBD, hemp, cannabinoids in the health and wellness segment with Smoke Wallin, CEO of Vertical Wellness. Many regulatory headwinds, but near-term hemp and CBD saturation will open up and level off. FDA still captive to pharma industry. Bigger opportunity for natural products in...
Recently announced provisional Q4 numbers are positive. Company has provided new information in recent conferences on product testing as the pipeline develops. Numerous potential revenue opportunities opening up for 2021 and beyond. For further details see: GW Pharma Wel...
CEO Jonathan Sandelman returns to the show to discuss AYR Strategies' recent deals and its steady rise to the top of the MSO pack. 7 M&A transactions in past 4 months. Very accretive deals for shareholders: great assets at a fair price. Want partners and shareholders to be exc...
CEO Jonathan Sandelman returns to the show to discuss AYR Strategies' recent deals and its steady rise to the top of the MSO pack. 7 M&A transactions in past 4 months. Very accretive deals for shareholders: great assets at a fair price. Want partners and shareholders to be exc...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process. Going the SPAC route. Cannabis grown in Colombia, being GMP-certified, LatAm r...
Refocused efforts after vape issues has Halo getting back to peak-level revenues; Two consecutive months of record revenues will push the company to profitability with economies-of-scale; Industry expectations are for doubling of overall revenues in the next 3-4 years offering an ...
SPAC week continues with Kyle Detwiler, CEO of Clever Leaves, a recent entrant to Nasdaq. Building one of the largest cannabis companies in the world using a much more capital efficient funding process. Going the SPAC route. Cannabis grown in Colombia, being GMP-certified, LatAm r...
Control in Senate was key to pass bills to support Cannabis industry. Expected permissive regulation on the sector will provide massive tailwind to US Cannabis operators. Many setbacks for the industry have high chances to be removed. Institution investing in US MSOs compared ...
It's SPAC week, and why not start with Subversive Capital and the biggest cannabis SPAC ever, launching this week: The Parent Company. Subversive Founder and Chairman Michael Auerbach joins us to discuss California as the tip of the spear and why it was always the focus. Creating ...
News, Short Squeeze, Breakout and More Instantly...
Amplify ETF Trust - Amplify Seymour Cannabis ETF Company Name:
CNBS Stock Symbol:
NYSE Market:
2024-01-19 07:30:51 ET The Leading Cannabis ETFs to Consider in 2024 Cannabis ETFs are garnering attention in 2024 as the industry shows promising growth. Key players like MJ, MSOS, and CNBS dominate this sector. These ETFs offer diversified exposure to cannabis-related stocks. This...
2023-10-27 07:30:02 ET Q4 2023’s Cannabis ETF Leaders: Where to Invest The cannabis sector continues to entice investors with its prospects for expansion and financial success as we take on the last quarter of 2023. Cannabis Exchange-Traded Funds (ETFs) have become popular for in...
2023-09-15 07:30:42 ET Top Marijuana ETFs for September 2023 In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory landscapes evolve and soc...